DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IMPLANON

« Back to Dashboard

Clinical Trials for Implanon

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00620464	A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2005-05-01	The primary purpose of this study is to demonstrate the bioequivalence of IMPLANON and Radiopaque IMPLANON.
NCT00725413	A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 4	2001-11-01	The primary purpose of this study is to investigate the contraceptive efficacy, safety and acceptability of Organon's subdermal etonogestrel implant in healthy female volunteers in various countries in order to obtain country-specific data.
NCT00828542	Safety of the Etonogestrel-Releasing Implant During the Puerperium of Healthy Women	Completed	University of Sao Paulo	N/A	2007-07-01	The purpose of this study to assess the safety of the etonogestrel-releasing subdermal implant (Implanon) inserted during the immediate puerperium of healthy women.
NCT00847587	Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant	Completed	University of Utah	Phase 4	2009-01-01	A highly effective single rod contraceptive implant is now available for use in the US. Delays in the insertion of the device until later in the postpartum period may negatively impact initiation rates. The objective of this study is to compare outcomes of early postpartum insertion (prior to postpartum hospital discharge) of the etonogestrel-releasing contraceptive implant with routine postpartum insertion at 4-8 weeks after delivery. Primary outcome of interest will be time to lactogenesis. Secondary outcomes will include rates of breastfeeding supplementation, infant growth, vaginal bleeding patterns, incidence of side effects, time to resume sexual intercourse after delivery, and incidence of missed routine postpartum follow-up. In addition, a subset of patients who randomize to early postpartum insertion will have expressed breastmilk ascertained for nutrient composition.

Clinical Trial Conditions for Implanon

Condition Name

Condition Name for Implanon
Intervention	Trials
Contraception	10
HIV	3
Post Partum	1
Continuation Rate of Contraceptive Implant	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Implanon
Intervention	Trials
Hemorrhage	4
Uterine Hemorrhage	3
Anemia, Sickle Cell	1
Endometriosis	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Implanon

Trials by Country

Trials by Country for Implanon
Location	Trials
United States	7
Brazil	5
Uganda	3
Egypt	2
Australia	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Implanon
Location	Trials
North Carolina	1
Minnesota	1
Massachusetts	1
Utah	1
South Carolina	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Implanon

Clinical Trial Phase

Clinical Trial Phase for Implanon
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	3
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Implanon
Clinical Trial Phase	Trials
Completed	11
Recruiting	4
Not yet recruiting	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Implanon

Sponsor Name

Sponsor Name for Implanon
Sponsor	Trials
University of Pittsburgh	4
Merck Sharp & Dohme Corp.	3
Chulalongkorn University	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Implanon
Sponsor	Trials
Other	31
Industry	5

Export unavailable in trial.
Subscribe for complete access.